RecruitingNCT04198740
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Studying Bullous pemphigoid
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Principal Investigator
- Marie-Claude Robert, MD, M.Sc, MD, FRCSCCentre hospitalier de l'Université de Montréal (CHUM)
- Intervention
- Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry(diagnostic_test)
- Enrollment
- 300 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2035
Study locations (2)
- Université du Québec à Montréal (UQAM) - Department of Chemistry, Montreal, Quebec, Canada
- Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada
Collaborators
Université du Québec a Montréal
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04198740 on ClinicalTrials.govOther trials for Bullous pemphigoid
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06291350Peridontal and Intestinal Microbiota in Patients With Gingival Scarring PemphigoidCentre Hospitalier Universitaire de Nice
- RECRUITINGNANCT06479018Deciphering IL-17-dependant Inflammatory Response in Bullous PemphigoidCHU de Reims
- RECRUITINGPHASE3NCT03295383Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane PemphigoidUniversity Hospital, Rouen